Conference Coverage: EHA 2023 – Focus on Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)

Expert perspectives on the latest therapeutic developments, treatment approaches, and implications for clinical decision-making regarding leukemia

June 10, 2023

Faculty Chair

Elias Jabbour, MD

MD Anderson Cancer Center, Houston, TX, USA

Faculty Members

Naval Daver, MD
MD Anderson Cancer Center, Houston, TX, USA

Guillermo Garcia-Manero, MD
MD Anderson Cancer Center, Houston, TX, USA

Alexander E. Perl, MD
Abramson Cancer Center, Penn Medicine, Philadelphia, PA, USA

Rami Komrokji, MD
Moffitt Cancer Center, Tampa, FL, USA

Jessica Altman, MD
Robert H. Lurie Comprehensive Cancer Center, Chicago, IL, USA


Download the meeting agenda

View Agenda

Sample Report

Start discovering the insights

View Report


  • New Developments in First-line Treatment of MDS
  • New Developments in Treatment of Relapsed/Refractory (R/R) MDS
  • Advances in AML: Newly Diagnosed
  • Advances in Acute Myeloid Leukemia (AML): Newly Diagnosed Elderly and/or Unfit
  • Advances in AML: R/R AML

Purchase Report

Thank you for your interest in our insights.

Complete the form below to receive additional information.